Details for 2013868063
Up to date per 01.04.2026
Actions
Details for 2013868063
Granted/Registered
European Patent
04.11.2015 A
20.04.2022 B1
27.12.2012
US
201261746499 P
13.03.2013
US
201361779604 P
04.10.2013
US
201361887129 P
C12P 21/02 20060101AFI20210517BHEP
Owner
NGM Biopharmaceuticals, Inc.333 Oyster Point Blvd. South San Francisco CA 94080US
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
LING, Lei411 Nantucket Street Foster City, CA 94404US
LUO, Jian992 Ventura Avenue Albany, CA 94796US
Information about Fees